▮ DFV TERMINAL
--:--:-- UTC SIGN IN
F1 Terminal / SONX

SONX — Sonendo, Inc.

—
· Health Care · Health Care Equipment & Supplies · CIK 1407973 ·
Last close
$1.01
Market Cap
$4.81M
52W High
$1.01
52W Low
$0.33
ADV30
99
Next earnings
—
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for endodontists. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2024 8,305,000 3,415,000 -5,638,000 -6,370,000 31,265,000 10,226,000 26,074,000
Sep 2024 8,036,000 3,310,000 -6,792,000 -7,536,000 38,131,000 13,096,000 27,165,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-7,245,000
Investing CF
$7,187,000
Financing CF
$-5,423,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-15.77
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-458,046,000
Inventory
$10,210,000
Receivables
$3,682,000
ST Investments
$1,401,000
EBIT TTM
$-12,032,000
Pretax Income TTM
$-13,905,000
Interest Exp TTM
$1,873,000
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$31,702,000
EBITDA
$-28,887,000
Free Cash Flow
$-12,798,125
Enterprise Value
$6,651,675
Total Cash
$11,627,000
Total Debt
$17,847,000
Shares Out
4,764,978
Trailing EPS
$-70.63
Book Value
$12.15
ROE
-199.6%
ROA
-33.3%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2024 31,702,000 -29,366,000 -28,033,000 31,265,000 26,074,000 — -24,652,000
Dec 2023 34,628,000 -59,265,000 -60,919,000 78,160,000 49,741,000 — -46,062,000
Dec 2022 41,656,000 -58,202,000 -57,050,000 137,285,000 55,330,000 — -61,072,000
Dec 2021 33,197,000 -44,145,000 -48,499,000 115,499,000 43,436,000 — -48,605,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.17

Peers — same industry

TickerNameMarket CapLastDaily %
WOK WORK Medical Technology Group LTD $4.76M $1.97 —
ALUR ALLURION TECHNOLOGIES, INC. $4.98M $4.98 —
CLGN CollPlant Biotechnologies Ltd $5.16M $0.27 —
SNOA Sonoma Pharmaceuticals, Inc. $5.26M $1.10 —
CODX Co-Diagnostics, Inc. $5.27M $1.44 —

Recent Insider Activity

No insider activity indexed for this ticker.
SEC EDGAR filings → · StockAnalysis.com → · OpenInsider →